Surowce roślinne i związki naturalne stosowane w chorobach układu oddechowego

• Autorzy: Nowak G. , Nawrot J.

Warianty tytułu

EN

Plant raw materials and natural compounds in diseases of respiratory system

• Języki publikacji: PL

Abstrakty

PL

Zasadność stosowania leków roślinnych w chorobach układu oddechowego wynika z tradycji i w wielu przypadkach dobrze udokumentowanego działania. W niniejszej pracy zaprezentowano ich podział na leki hamujące odruch kaszlowy, działające do nich przeciwnie, tzn. wykrztuśnie, przedstawiono także surowce o silnym działaniu przeciwbakteryjnym i takie, które powodują efekt spazmolityczny w mięśniach gładkich dróg oddechowych.

EN

The relevance of herbal medicine in respiratory system diseases is a result of the traditional use and, in many cases, well-documented activity of plant raw materials. In the present work the pertinent medicaments are divided into the drugs inhibiting cough and the ones with the opposite, that is expectorant activity. There are also presented raw materials of strong antibacterial activity and those inducing spasmodic effect on the smooth muscles of the respiratory tract.

Słowa kluczowe

PL

zdrowie czlowieka; choroby czlowieka; choroby ukladu oddechowego; choroby gornych drog oddechowych; kaszel; zapalenie gardla; leki naturalne; leki roslinne; surowce roslinne; ziololecznictwo; leki wykrztusne; leki przeciwkaszlowe; prawoslaz lekarski; Althaea officinalis; slaz dziki; Malva sylvestris; porost islandzki; Lichen islandicus; podbial pospolity; Tussilago farfara; dziewanna kutnerowata; Verbascum phlomoides; babka lancetowata; Plantago lanceolata; tymianek pospolity; Thymus vulgaris; tymianek hiszpanski; Thymus zygis; biedrzeniec anyz; Pimpinella anisum; eukaliptus galkowy; Eucalyptus globulus; sosna zwyczajna; Pinus sylvestris; bluszcz pospolity; Hedera helix; pierwiosnek wiosenny; Primula veris; pierwiosnek wyniosly; Primula elatior; krzyzownica wirginijska; Polygala senega; lukrecja gladka; Glycyrrhiza glabra; mydlnica lekarska; Saponaria officinalis; biedrzeniec mniejszy; Pimpinella saxifraga; biedrzeniec wielki; Pimpinella major; rukiew lekarska; Nasturtium officinale; chrzan pospolity; Armoracia rusticana; dogleda wielka; Grindelia robusta; rosiczka okraglolistna; Drosera rotundifolia; brodaczka wlasciwa; Usnea barbata; brodaczka nadobna; Usnea florida; szalwia lekarska; Salvia officinalis; pastwin trojprecikowy; Krameria triandra; pelargonia afrykanska; Pelargonium sidoides; drzewo herbaciane; Melaleuca alternifolia; wierzba biala; Salix alba; wierzba purpurowa; Salix daphnoides; lipa drobnolistna; Tilia cordata; lipa szerokolistna; Tilia platyphyllos; bez czarny; Sambucus nigra; roza dzika; Rosa canina; roza alpejska; Rosa pendulina; roza pomarszczona; Rosa rugosa; wiazowka blotna; Filipendula ulmaria; farmakologia; badania farmakologiczne

• Wydawca: -
• Czasopismo: Herba Polonica
• Rocznik: 2009
• Tom: 55
• Numer: 4
• Opis fizyczny: s.178-213,rys.,bibliogr.

Twórcy

autor

Nowak G.

• Katedra i Zakład Naturalnych Surowców Leczniczych i Kosmetycznych, Uniwersytet Medyczny im. K. Marcinowskiego w Poznaniu, ul.Mazowiecka 33, 60-623 Poznań

autor

Nawrot J.

• Katedra i Zakład Naturalnych Surowców Leczniczych i Kosmetycznych, Uniwersytet Medyczny im. K. Marcinowskiego w Poznaniu, ul.Mazowiecka 33, 60-623 Poznań

Bibliografia

• 1. ESCOP Monographs. European Scientific Cooperative On Phytotherapy. Althaeae radix. 2nd ed. 2003:32-5.
• 2 Nosalo’ova G, Strapková A, Kardosová A, Capek P, Zathureckỳ L, Bukovská E. Antitussive action of extracts and polysaccharides of Marshmallow (Althaea officinalis L., var. robusta). Pharmazie. 1992; 47:224-6.
• 3. Sutowska M, Nosalova G, Franova S, Kardosova A. The antitussive activity of polysaccharides from Althaea officinalis L. var. robusta, Arctium lappa L. var herkules and Prunus perlica L., Batsh. Bratisl. Lek Listy 2007; 108:93-9.
• 4. Franz G. Polysaccharides in Pharmacy; cure and applications and future concepts. Planta Med 1989; 33:493-7.
• 5. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Marshmallow Leaf. Marshmallow Root. 1st ed. American Botanical Council. Newton 2000:244-8.
• 6. EMEA. European Medicines Agency. Althaea officinalis L., Radix. London. 2009.
• 7. ESCOP Monographs European Scientific Cooperative On Phytotherapy. Malvae flos.2nd ed. Supplement. Thieme 2009:157-9.
• 8. Weiss RF, Fintelmann V. Herbal Medicine. 2nd ed. Thieme 2000:185-7.
• 9. Ingolfsdotir K, Breu W, Huneck S, Gudjonsdotir CA, Miller-Jakic B, Wagner H. In vitro inhibition of 5-lipooxygenase by protolichesterenic acid from Cetraria Islandica (Iceland moss). Phytomedicine 1998; 5:333-339.
• 10. Kumar KCS, Muller K. Lichen metabolites. 1. Inhibitory action against leukotriene B4 biosynthesis by a non-redox mechanism. J Nat Prod 1999; 62:817-20.
• 11. Kempe C, Grüning H, Stasche N, Hörmann K. Isländiach-Moos-Pastillen zur Prophylaxe bzw. Heilungvon oralen Scleinbautiriitationen und ausgetrockneter achen-schlemihaut. Laryngo-Rhino-Otol 1997; 76:186-8.
• 12. Vorberg G. Fiechtenwirkstoffe lindern Reizzustände der Atemwege. Neben entzündungshemmenden Eigenschaffen wirkt sich der Scleimhautschutz besonders günstig aus. Arztl Praxis 1981; 33:3068.
• 13. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Iceland Moss.1st ed. American Botanical Council. Newton 2000:212-14.
• 14. Weiss RF, Fintelmann V. Herbal Medicine. 2nd ed. Thieme 2000:190-1.
• 15. ESCOP Monographs. European Scientific Cooperative On Phytotherapy. Lichen islandicus. 2nd ed. 2003:286-9.
• 16. Weiss RF, Fintelmann V. Herbal Medicine. 2nd ed. Thieme 2000:187-8.
• 17. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Mullein Flower.1st ed. American Botanical Council. Newton 2000:270-2.
• 18. EMEA. European Medicines Agency. Verbascum thapsus L., V. densiflorum Bertol. and V. phlomoides Flos. London 2008.
• 19. Ravn H, Nishibe S, Sasahara M, Xuebo L. Phenolic compounds from Plantago asiatica. Phytochemistry. 1990; 29;3627-31.
• 20. ESCOP Monographs. European Scientific Cooperative On Phytotherapy Plantaginis lanceolatae folium/herba. 2nd ed. 2003:383-7.
• 21. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Plantain.1st ed. American Botanical Council. Newton 2000:307-10.
• 22. Schulz V, Hänsel R, Blumenthal M, Tyler VE. Rational Phytotherapy. Springer. Berlin, Heidelberg, New York. 2004:202-11.
• 23. Van den Broucke C, Lemli J.A. Spasmolytic activity of the flavonoids from Thymus vulgaris. Pharm. Weekbl. Sci. Ed. 1983; 5:9-14.
• 24. Christoffel V, Schwenk U, Eberhard G, Morgenstern E, Ziska T et al. Pharmacological profiling of the Thymus vulgaris preparation BNO1018. Symposium Phytopharmaka-Forschung 2000. Bonn 1998:27-8.
• 25. ESCOP Monographs. European Scientific Cooperative On Phytotherapy. Thymi herba. 2nd ed. 2003:505-10.
• 26. Weiss RF, Fintelmann V. Herbal Medicine. 2nd ed. Thieme 2000:197-99.
• 27. EMEA. European Medicines Agency. Thymus vulgaris L. and Thymus zygis L. Herba. London 2007.
• 28. Rossoli I, Mirmostafa S.A. Antibacterial properties of Thymus pubescens and Thymus serpyllum essential oils. Fitoterapia. 2002; 73:244-50.
• 29. Müller-Limmroh W, Fröchilich H.H. Wirkungsmachweis einiger phytotherapeutchscher Ekspektorantien auf den mukoziliaren Transport Fortschr Med 1980; 98:95-101.
• 30. ESCOP Monographs. European Scientific Cooperative On Phytotherapy. Anisi fructus. 2nd ed. 2003:36-42.
• 31. EMEA. European Medicines Agency. Pimpinella anisum L. Aetheroleum. London 2007.
• 32. ESCOP Monographs. European Scientific Cooperative On Phytotherapy. Eucalypti aetheroleum 2nd ed. 2003:150-6.
• 33. Kurzawa R, Horoszkiewicz-Hassan M, Nowak G. Zastosowanie leków roślinnych w chorobach układu oddechowego. Pediatria po dyplomie. Wydanie specjalne. Wrzesień 2008:62-8.
• 34. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Eucalyptus leaf. Eucalyptus Oil. 1st ed. American Botanical Council. Newton 2000:118-25.
• 35. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Pine Needle Oil. 1st ed. American Botanical Council. Newton 2000:304-6.
• 36. Cis J, Nowak G. Ziołowa apteka – układ oddechowy. W: Zioła z apteki natury.Poznań 2006:222-7.
• 37. Sieben A, Prenner L, Sorkalla T, Wolf A, Jakobs D, et al. Alpha-hederin, but not hederacoside C and hederagenin from Hedera helix, affects the Winding behavior, Dynamics and regulation of beta 2-adrenergic receptors. Biochemistry 2009; 48:3477-82.
• 38. Runkei F, Prenner L, Haberlein H. In-vitro-Studien. Ein Beitrag zum Wirkmechanismus von Efeu. (in Eng.) Pharm Ztg 2005; 4:27-32.
• 39. Balbot Yu, Prokhorov E, Mokia S, Yurtseva A. Comparing the efficacy and safety of high-concentrate (5-7,5;1) ivy leaves extract and Acetylcysteine for treatment of children with acute bronchitis. Drugs of Ukraine 2004; 11:1-4.
• 40. ESCOP Monographs. European Scientific Cooperative On Phytotherapy. Hederae helices folium. 2nd ed. 2003:241-7.
• 41. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Ivy Leaf. 1st ed. American Botanical Council. Newton 2000:215-17.
• 42. Rao GS, Sinsheimer JE, Cochran KW. Antiviral activity of triterpenoid saponins containing acylated β-amyrin aglycones. J Pharm Sci 1974; 63:471-3.
• 43. Wolters B. Die verbreitung antibiotischer Eigenschaften bei Saponindrogen. Dtsch. Apoth. Zeitung. 1966; 106:1729-1753.
• 44. ESCOP Monographs. European Scientific Cooperative On Phytotherapy. Primulae radix. 2nd ed. 2003:407-409.
• 45. EMEA. European Medicines Agency. Primula veris L. and Primula elatior (L.) Hill. Radix. London 2007.
• 46. EMEA. European Medicines Agency. Primula veris L. and Primula elatior (L.) Hill. Flos. London 2007.
• 47. Boyd EM, Palmer ME. The effect of Quilaia, Senega, Squil, Crindelia, Sanguinaria, Chionanthus and Dioscorea upon the output or respiratory tract fluid. Acta Pharmacol 1946:221-9.
• 48. ESCOP Monographs. European Scientific Cooperative On Phytotherapy. Polygalae radix. 2nd ed. 2003:400-6.
• 49. ESCOP Monographs. European Scientific Cooperative On Phytotherapy. Liquiritiae radix. 2nd ed. 2003:297-305.
• 50. Weiss RF, Fintelmann V. Herbal Medicine. 2nd ed. Thieme 2000:193-5.
• 51. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Watercress. 1st ed. American Botanical Council. Newton. 2000:404-7.
• 52. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Horseradish. 1st ed. American Botanical Council. Newton. 2000:205-7.
• 53. ESCOP Monographs European Scientific Cooperative On Phytotherapy. Grindeliae herba.2nd ed. Supplement. Thieme 2009:131-4.
• 54. Weiss RF, Fintelmann V. Herbal Medicine. 2nd ed. Thieme 2000:199-200.
• 55. Cabrera C. Materia Medica - Usnea sp. Eur. J Herbal Med 1996; 2:11-13.
• 56. Dobrescu D, Tanasescu M, Mezdrea A. Contributions to the complex study of some lichens – Usnea genus. Pharmacological study on Usnea barbata and Usnea birta species. Rom J Physiol 1993; 30:101-7.
• 57. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Usnea. 1st ed. American Botanical Council. Newton. 2000:385-8.
• 58. ESCOP Monographs. European Scientific Cooperative On Phytotherapy. Salviae officinalis folium. 2nd ed. 2003:452-5.
• 59. EMEA. European Medicines Agency. Salvia officinalis L. Folium. Flos. London 2009.
• 60. ESCOP Monographs European Scientific Cooperative On Phytotherapy. Ratanhiae radix.2nd ed. Supplement. Thieme. 2009:213-15.
• 61. Schoetz K, Erdelmeier C, Germer S, Hauer H. A detailed view on the constituents of EPs 7630. Planta Med. 2008; 74:667-74.
• 62. Kolodziej H. Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo. Phytomedicine 2007; 14:9-17.
• 63. Schulz V, Hänsel R, Blumenthal M, Tyler VE. Rational Phytotherapy. Springer. Berlin, Heidelberg, New York. 2004:213-14.
• 64. Golovatiuk A, Tschtschalin A.G. Wirsamkeit einen Ekstrakten aus Pelargonium sidoides (EPS 7630) versus Placebo bei aktuer Bronchitis. In|: Schulz V, Reitbrok N, Roots I, Loew D. (eds). Phytopharmaka VII - Forschung und klinische Anwendung. Steinkopff-Verlag, Darmstadt 2002:3-12.
• 65. Bachert C, Schapowal A, Funk P, Kieser M. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. J App Microbiol 2009; 106:1184-93.
• 66. Conrad A, Frank U. Extract of Pelargonium sidoides (EPs 7630) displays anti-infective properties by enhanced phagocytosis and differential modulation of host-bacteria interactions. Wien Med Wochenschr 2007; 157:331-6.
• 67. Mondello F, Girolamo A, Scaturro M, Ricci ML. Determination of Legionella pneumophila susceptibility to Melaleuca alternifolia Cheel (tea tree) oil by an improved broth micro-dilution method under vapour controlled conditions. J Microbiol Methods 2009; 77:243-8.
• 68. D’Arrigo M, Ginestra G, Mandalari G, Furneri PM, Bisignano G. Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli. Phytomedicine. 2009 Aug 19 (in Press).
• 69. Pisseri F, Bertoli A, Nardoni S, Pinto L, Pistelli L. et al. Antifungal activity of tea tree oil from Melaleuca alternifolia against Trichophyton equinum: an in vivo assay. Phytomedicine 2009;16:1056-8.
• 70. Price Sh, Price L. Aromatherapy for Health Professionals. 3ed. Churchill Livingstone Elselvier. Philadelphia 2007:123.
• 71. Akao T, Yoshino T, Kobashi K, Hattori M. Evaluation of salicin as an antipyretic prodrug that does not cause gastric injury. Planta Med. 2002; 68:714-18.
• 72. Chrubasik S, Eisenberg E, Balan E, Weiberger T, Luzzati R, Conradt C. Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. Am. J. Med. 2000; 109:9-14.
• 73. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Willow bark. 1st ed. American Botanical Council. Newton. 2000:408-412.
• 74. ESCOP Monographs. European Scientific Cooperative On Phytotherapy. Salicis cortex. 2nd ed. 2003:445-51.
• 75. EMEA. European Medicines Agency. Salix. Cortex. London 2009.
• 76. Blumenthal M., Goldberg A., Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Linden Flower. 1st ed. American Botanical Council. Newton. 2000:240-3.
• 77. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Elder Flower. 1st ed. American Botanical Council. Newton. 2000:103-5.
• 78. ESCOP Monographs European Scientific Cooperative On Phytotherapy.Rosae pseudo-fructus.2nd ed. Supplement. Thieme. 2009:216-21.
• 79. Larsen E, Kharazmi A, Christensen SB. An inflamatory galaktolipid from rose hip (Rosa canina) that inhibits chemotaxis of human peripheral blood neutrophils in vitro. J. Nat. Prod. 2003; 22:982-4.
• 80. ESCOP Monographs. European Scientific Cooperative On Phytotherapy. Filipendulae ulmariae herba. 2nd ed. 2003:157-61.
• 81. Blumenthal M, Goldberg A, Brinckann J. Herbal Medicine. Expanded Commission E Monographs. Meadowsweet. 1st ed. American Botanical Council. Newton. 2000:253-6.
• 82. Dewick PM. Medicinal Natural Products. John Wiley & Sons. Chichester. New York. Toronto 1998:128-9.
• 83. Davis JE. Are one or two dangerous? Methyl salicylate exposure in toddlers. J Emerg Med 2007; 32:63-9.
• 84. Botka M, Colquhoun-Flannery W, Leighton S. Laryngeal oedema caused by accidental ingestion of Oil of Wintergreen. Int J Pediatr Othorhinolaryngol 2001; 58:229-32.